Vital Signs - Biopharmaceutical Drug Delivery: Going Beyond Injection
Vital Signs - Biopharmaceutical Drug Delivery: Going Beyond Injection
RELEASE DATE
18-Oct-2010
18-Oct-2010
REGION
North America
North America
Research Code: 9561-00-B1-00-00
SKU: HC00606-NA-MR_04079
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00606-NA-MR_04079
Description
This issue of Vital Signs, released on October 18, 2010, provides a strategic overview of key issues and trends relating to advances in biopharmaceutical drug delivery. Additionally, a company spotlight is provided for QRxPharma Ltd., a clinical stage specialty pharmaceutical company focused on the development and commercialization of new therapies for CNS disorders and the management of pain. Reimbursement and regulatory news from the FDA is also provided for the week of September 27, 2010.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on October 18, 2010, provides a strategic overview of key issues and trends relating to advances in biopharmaceutical drug delivery. Additionally, a company spotlight is provided for QRxPharma Ltd., a clinical stage specialty pharmaceutical company focused on the development and commercialization of new therapies for CNS disorders and the management of pain. Reimbursement and regulatory news from the FDA is also provided for the week of September 27, 2010.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-B1-00-00 |
Is Prebook | No |